"SILVAMP TB LAM" rapid urine tuberculosis test predicts mortality in patients hospitalized with human immunodeficiency virus in South AfricaMore about Open Access at the Crick
Authors listBianca Sossen Tobias Broger Andrew D Kerkhoff Charlotte Schutz Andre Trollip Emmanuel Moreau Samuel G Schumacher Rosie Burton Amy Ward Robert Wilkinson David A Barr Mark P Nicol Claudia M Denkinger Graeme Meintjes
Reducing diagnostic delay is key towards decreasing tuberculosis-associated deaths in people living with HIV. In tuberculosis patients with retrospective urine testing, the point-of-care Fujifilm SILVAMP TB LAM (FujiLAM) could have rapidly diagnosed tuberculosis in up to 89% who died. In FujiLAM negative patients, the probability of 12-week survival was 86-97%.
Journal Clinical Infectious Diseases
Issue number 8